Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Bertin Bioreagent
anti-TAF3 (formerly TAFII140), mAb (2F5)
As low as
664
CHF
CHF 664.00
In stock
Only %1 left
BRT-G01080-R100100 µlCHF 664.00
NEW

Product Details | |
---|---|
Synonyms | Transcription Initiation Factor TFIID Subunit 3; TATA-Box Binding Protein-Associated Factor 3; TAFII140; TBP-associated Factor 3 |
Product Type | Monoclonal Antibody |
Properties | |
Clone | 2F5 |
Isotype | Mouse IgG1κ |
Source/Host | Mouse |
Immunogen/Antigen | Synthetic peptide. |
Application | ELISA, Western Blot, Immunoprecipitation, Immunocytochemistry. Recommended dilutions: 1/500-1/5000. |
Specificity | Recognizes human and mouse TAF3. |
Formulation | Liquid. Does not contain any preservative. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Bertin Bioreagent |
Shipping and Handling | |
Shipping | BLUE ICE |
Long Term Storage | -20°C |
Handling Advice | Avoid freeze/thaw cycles. |
Use/Stability | Stable for at least 3 years after receipt when stored at -20°C. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
Description
TAF3 is a transcription cofactor and a component of the TFIID complex, which is essential for RNA polymerase II-dependent transcription initiation. It plays an important role in regulating gene expression and transcription initiation. TAF3 is a core subunit of TFIID, a multi-protein complex that recognizes core promoter regions and recruits RNA polymerase II to initiate transcription. TAF3 is involved in the assembly and stabilization of the TFIID complex, ensuring proper interaction between TFIID and other transcription factors. TAF3 participates in chromatin remodeling by recruiting coactivators and chromatin-modifying enzymes. TAF3 is critical for proper gene expression during development, influencing cell differentiation and embryonic growth. Altered expression or mutations in TAF3 may disrupt transcription and contribute to oncogenesis and tumor progression.